Patterns of Bone Mineral Density Testing in Men Receiving Androgen Deprivation for Prostate Cancer

Practice guidelines recommend bone mineral density (BMD) monitoring for men on androgen deprivation therapy (ADT) for prostate cancer, but single center studies suggest this is underutilized. We examined determinants of BMD testing in men receiving ADT in a large population-based cohort of men with prostate cancer. Retrospective cohort study. We used the… CONTINUE READING